Doximity Stock: Bull vs. Bear | The Motley Fool
Is this beaten-down healthcare information technology stock a buy?
Source: fool.com
📰 Patrick Bafuma News
Patrick Bafuma News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Patrick Bafuma. Real-time updates on events, politics, business and more.
3 Cathie Wood Stocks That Could Deliver Monster Returns
Here's why our roundtable likes 10x Genomics, Beam Therapeutics, and Recursion Pharmaceuticals.
Cathie Wood Patrick Bafuma Cathie Wood Ark Taylor Carmichael Recursion Pharmaceuticals Recursion Pharmaceuticals Ark Genomic Revolution
Source: fool.com
3 Cathie Wood Stocks That Could Deliver Monster Returns
Here's why our roundtable likes 10x Genomics, Beam Therapeutics, and Recursion Pharmaceuticals.
Cathie Wood Patrick Bafuma Cathie Wood Ark Taylor Carmichael Recursion Pharmaceuticals Recursion Pharmaceuticals Ark Genomic Revolution
Source: fool.com
3 Med-Tech Stocks With Incredible Potential
Here's why our roundtable likes iRhythm, SeaSpine Holdings, and Owlet.
Patrick Bafuma George Budwell Seaspine D Technology Drug Administration Seaspine Holdings Motley Fool
Source: fool.com
My Favorite Biotech | The Motley Fool
Here's why three Fool.com contributors love 10x Genomics, Axsome Therapeutics, and Doximity.
United States George Budwell Axsome Patrick Bafuma Taylor Carmichael Doximity Drug Administration Axsome Therapeutics
Source: fool.com
My Favorite Biotech | The Motley Fool
Here's why three Fool.com contributors love 10x Genomics, Axsome Therapeutics, and Doximity.
United States George Budwell Axsome Patrick Bafuma Taylor Carmichael Doximity Drug Administration Axsome Therapeutics
Source: fool.com
Up 1,000% in 5 Years? These Healthcare Stocks Could Pull It Off.
Here's why our roundtable loves Legend Biotech, Heron Therapeutics, and Pieris Pharmaceuticals.
United States Patrick Bafuma George Budwell Taylor Carmichael Taylor Carmichael Pieris Pharmaceuticals American Society For Clinical Oncology
Source: fool.com
3 Biotechs That Will Soar Regardless of COVID-19
In the healthcare markets, much time and energy have been focused on COVID-19. But there are some amazing opportunities outside the COVID space.
George Budwell Sana Patrick Bafuma Taylor Carmichael Pieris Pharmaceuticals Drug Administration Pieris Pharmaceuticals Video Communications Zoomtopia
Source: fool.com
Better Buy: Ocugen or Novavax? | The Motley Fool
Will either of these hopeful vaccine makers continue to thrash the market?
New Zealand South Korea Patrick Bafuma Keith Speights Emergency Use Authorization Investigational New Drug Application
Source: fool.com
10x Genomics Stock: Bull vs. Bear | The Motley Fool
After a hot start, the stock has recently lagged the market. Is now a good time to buy?
Source: fool.com